Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

CMB-401, an immunoconjugate for the targeted treatment of EOC

June 25, 1998

Positive phase II results for GMK vaccine presented at NCI-EORTC meeting

June 25, 1998

NeoRx begins phase I trial of Pretarget technology in lymphoma

June 25, 1998

Progenics receives payment for cancer vaccine milestone

June 24, 1998

IL-2 fusion protein produces remission in late-stage refractory CTCL

June 23, 1998

Novopharm Biotech's NOVOMAb-G2 IgM completes phase I

June 23, 1998

Russian scientists evaluate the antitumor activity of betaleukin

June 22, 1998

CBER requests additional information for Ontak BLA

June 19, 1998

ICO25 MAb suppresses tumor growth and prolongs survival in preclinical model of colon cancer

June 19, 1998

New dosing regimen of Avax melanoma vaccine results in improved outcome

June 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
Other news to note for May 1, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: AC Immune, Aptose, Astrazeneca, Bioreference Health, Cardioline,...